Resources
- Current Drug Development Status for Stroke
- Injury Mechanisms in Stroke
- What Is Stroke
- Research Resources
- In Vitro and In Vivo Models of Ischemic Stroke
- In Vitro and In Vivo Models of Hemorrhagic Stroke
- 3D Cortex Spheroids for Ischemic Stroke Modeling
- In Vitro Blood-Brain Barrier Models for Ischemic Stroke
- Oligodendrocytes (OLs) and Ischemic Brain Injury
- Advances in Understanding Stroke-Induced Blood-Brain Barrier Disruption: Pathophysiology and Inspection Technique
- The Dual Role of Hepatocyte Growth Factor in Ischemic Stroke
- Mitochondrial Dysfunction in Ischemic Stroke
- Neuroinflammation in Stroke
- Enhancing Therapy for Ischemic Stroke—Innovative Clot Busting Strategies
- Overview of Hepatic Metabolism in Ischemic Stroke
- Applications of Hydrogel Scaffolds for Ischemic Stroke Therapy
- Behavioral Tests in Rodent Models of Stroke
- High-Throughput Screening Platforms in the Discovery of Novel Drugs for Stroke
- Neurotoxicity of Tissue Plasminogen Activator (tPA)
- Nest-building Behavior Test in Mouse Models of Stroke
- Ischemic Stroke In Vitro Assays
- In Vitro Testing of Novel Thrombolytics in Stroke
- Open Field Test in Rodent Models of Stroke
- Analysis of the Mechanism of Action (MoA) of Stroke Drugs
- Biochemical Assays and Histological Analysis in Animal Models of Stroke
- The Role of Plasma Protein Binding in Drug Delivery to Brain
- Ames Test for Genotoxicity Testing in Stroke Drug Development
- Cognitive Tests in Rodent Models of Stroke
- Cylinder Test in Rodent Models of Stroke
- Cytochrome P450 in Stroke
- Glutamate Excitotoxicity in Stroke
- Microglia in Ischemic Stroke
- Morris Water Maze Test in Rodent Models of Stroke
- Neutrophil Extracellular Traps (NETs) Represent a New Potential Target for Stroke Treatment
- P-glycoprotein Deficient Mice for Blood-Brain Barrier Studies in Stroke
- P-Glycoprotein Expression in the Blood–Brain Barrier After Cerebral Ischemia
- Porcine Stroke Models
- RNA in Stroke Pathology, Diagnostics, and Therapeutics
- Routes of Administration of Stem Cells in Stroke
- Stem Cell Therapy for Stroke
- Targeting PROTAC BET Proteins for Degradation with dBET1 Ameliorates Ischemic Stroke
- Techniques for Stroke Infarct Volume Measurement in Rodents
- Boosting Neurpolasticity to Accelerate Stroke Recovery
- Glutathione As a Potential Antioxidant for Ischemic Stroke Therapy
- Magnetic Resonance Imaging in Stroke
- Overview of Anxiety After Stroke
- Overview of Post-Stroke Depression
- Pathological Processes of Neuronal Autophagy-Lysosome Dysfunction After Ischemic Stroke
- Pathophysiology and Potential Therapies of Cerebral Edema After Ischemic Stroke
- Post-stroke Neurogenesis As a Potential Target for Therapy
- The Mechanism and Treatment of Post-Stroke Pain
- The Role of Autophagy in Ischemic Stroke
- Venous Thromboembolism After Stroke and Neutrophil Activation
- Assessment of Brain Penetration in Stroke Drug Discovery
- Channels Involved in Ischemia-Mediated Neuronal Damage
- Coronal Sections of Brain Lesion Caused by Stroke
- Elevated-Plus Maze Test in Rodent Models of Stroke
- Nanomaterials in Stroke
- Neuropathy After Stroke
- RotaRod Test in Rodent Models of Stroke
- Seizures and Epilepsy After Stroke
- Spreading Depolarization in Stroke
- Therapeutic Potential of Intranasal Drug Delivery in Preclinical Stroke Studies
- Biomarkers in Stroke
- Assessment of Hand Motor Function in NHP Models of Ischemic Stroke
- Technical Notes
- Optimizing Stroke Drug Discovery: Surface Plasmon Resonance Techniques and their Applications
- Corneal Confocal Microscopy Detects Corneal Nerve Damage in Stroke
- Techniques for Visualizing Cell Death in Experimental Cerebral Stroke
- H&E Staining and Stroke
- Antifades & Mounting Media
- Methods for Monitoring Autophagy After Ischemic Stroke
- Autofluorescence in Brain Tissues Affected by Stroke
Online Inquiry